MARSHALL WACE, LLP - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 37 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$8,580,000
+34.0%
849,472
+33.1%
0.02%
+46.2%
Q2 2022$6,401,000
+1.8%
638,195
+1.5%
0.01%
+8.3%
Q1 2022$6,289,000
+1.2%
628,881
+0.3%
0.01%
+9.1%
Q4 2021$6,214,000627,0170.01%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2021
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders